Stock daily read

What happened with CTEV today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

CTEV in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Claritev Corporation checks medical claims for excessive charges and negotiates or recommends reimbursement amounts for providers outside a health plan’s network. Its Claims Intelligence Solutions generate most revenue; Network Solutions also let payers use discounts negotiated with contracted healthcare providers. Claritev processes transactions rather than delivering care, deciding claims or paying medical bills.

Its paying clients are typically private health-plan payers and third-party administrators that bring its services to employers and other plan sponsors. Most revenue comes from self-insured plans, where employers or sponsors bear medical costs. Fees generally depend on savings, with some services charged per covered employee or member per month. Payers make the final claim decisions and may not accept all the savings Claritev identifies.

The business depends on clients continuing to send claims, the populations they cover and the savings Claritev can identify. Two large clients supply a substantial share of revenue, and contracts generally allow termination on short notice without minimum usage commitments. Provider discounts also underpin its network services. The No Surprises Act governs certain out-of-network payments and has affected some business lines; state rules can restrict which plans may access network discounts.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in CTEV’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

CTEV says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

Claritev’s results depend chiefly on commercial health-plan claims volumes, savings-based fees and keeping large payer clients, with Optum and Cotiviti important payment-integrity rivals missing from this list.

  • Conduent competes with Claritev for healthcare payers’ business by identifying improper claims charges and improving payment accuracy. The overlap is in Claritev’s payment and revenue integrity services, where fees generally depend on the savings achieved for clients.

  • ExlService Holdings (EXL) competes with Claritev for health-payer spending on services that check claims for payment errors, analyze claims and reduce medical costs.

Agenda

in 7 daysTue, Oct 27

  1. Time to be announced

    ExlService Holdings, Inc. earningsEXLS

    ExlService’s report will show whether health payers are still paying for claims analysis and medical-cost reduction, and how much competition Claritev faces for that spending.

in 8 daysWed, Oct 28

  1. 2:00 PMET

    Fed Interest Rate Decision

    For Claritev, the Fed’s decision on its benchmark interest rate matters because higher rates can raise the cost of its variable-rate debt, leaving less cash for operations and investment.

in 20 daysMon, Nov 9

  1. Time to be announced
    Major

    Claritev Corporation earningsThis company

    Claritev’s report will show whether greater client use of its claims and provider-network services is growing its core business, or whether client and program losses and one-off work still obscure the trend.